Registry for individuals diagnosed with lung cancer

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This observational study aims to collect data from participants diagnosed with stage I lung cancer who are undergoing segmentectomy. Participants will complete questionnaires before surgery, and at two intervals post-surgery (2-4 weeks and 6 months). The study focuses on gathering patient-reported outcomes to better understand the experiences and recovery of lung cancer patients. The data collected will help inform future treatment approaches and patient care strategies.

Why it matters

Who can join: the full rules

Inclusion Criteria:

* Age ≥18 years
* Patients suitable for segmentectomy, according to the treating surgeon
* Clinical Stage I with suspected NSCLC, classified preoperatively based on the AJCC TNM staging manual, 9th edition o Note: Tissue diagnosis of NSCLC is not required before enrollment. A pathologic diagnosis of NSCLC may be confirmed preoperatively with biopsy, intraoperatively with frozen section, or postoperatively on final pathology

Exclusion Criteria:

* Actively receiving lung cancer treatment or a history of lung cancer in the previous 5 years
* History of chemotherapy or radiation therapy for a previous lung cancer
* Synchronous secondary cancer in the lung or elsewhere in the body at the time of surgery
* Carcinoid tumors
* History of other malignancies within the past 3 years, with the exception of non-melanoma skin cancer, superficial bladder cancer, and carcinoma in situ of the cervix
* Actively receiving treatment for other malignancies
* Cases of lobectomy in conjunction with segmentectomy from another lobe and ≥2 segmentectomies from different lobes either en bloc or separate will be excluded from the primary analysis.

  * Multi-segmental resection from the same lobe is not a criterion for exclusion.

Where it's running

• University of Arizona (Data Collection Only)
  Tucson, Arizona, United States Recruiting
• University of California San Diego (Data collection)
  San Diego, California, United States Recruiting
• Rush University Medical Center (Data collection only)
  Chicago, Illinois, United States Recruiting
• Endeavor Health
  Evanston, Illinois, United States Recruiting
• Massachusetts General Hospital Cancer Center (Data Collection Only)
  Boston, Massachusetts, United States Recruiting
• Brigham and Women's Hospital (Data Collection Only)
  Boston, Massachusetts, United States Recruiting

Study contacts

• Principal investigator: David Jones, MD — Memorial Sloan Kettering Cancer Center
• Study coordinator: David Jones, MD
• Email: jonesd2@mskcc.org
• Phone: 212-639-6428

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Microwave ablation for treating lung cancer nodules

  This study is testing a new microwave treatment for destroying small lung cancer nodules to see if it is safe and effective for patients.

  Recruiting Beth Israel Deaconess Medical Center · Boston, Massachusetts · NCT05281237

• Using a new device to treat lung cancer with targeted radiation

  This study is testing a new device that delivers targeted radiation to treat lung cancer in the upper lobes of the lungs while trying to protect nearby healthy tissues.

  Recruiting Phase 2 CivaTech Oncology · New York, New York · NCT03290534

• ePRO in advanced lung cancer: emotional distress, brain metastasis, and symptom burden

  This study tests how patients with advanced lung cancer—some with brain metastases—report emotional distress and symptoms over time using electronic questionnaires.

  Recruiting Tongji Hospital · Hubei, Wuhan · NCT07912190

• Urine VOC Test to Detect Lung Cancer in Never Smokers

  A urine test that looks for volatile compounds is tested to see if it can help detect lung cancer in adults who have never smoked.

  Recruiting Thomas Jefferson University · Philadelphia, Pennsylvania · NCT07871656

• SI-B036 safety test in advanced and metastatic solid tumors

  This early-phase study checks whether SI-B036 is safe and tolerable in adults with advanced or metastatic solid cancers who have had prior therapy.

  Recruiting at 4 sites Phase 1 SystImmune Inc. · New Haven, Connecticut and 6 other locations · NCT07857616

• Guaraná Supplement for Cancer-Related Fatigue in People Undergoing Treatment

  This study tests whether taking guaraná capsules helps reduce cancer-related fatigue and improve quality of life in adults with breast, lung, colorectal, or gastric cancer who are actively receiving treatment.

  Recruiting Centro de Tratamiento e Investigación sobre Cáncer, Luis Carlos Sarmiento Angulo · Bogotá, Bogota D.C. · NCT07816263

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.